Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y017625 | — |
no patient symptoms have been reported; an adult dose of VAQTA was inadvertently administered to a pediatric patient; an adult dose of VAQTA was inadvertently administered to a pediatric patient; This spontaneous report was received from a nurse regarding a 17-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 25-AUG-2025, the pediatric patient was inadvertently vaccinated with an adult dose of Hepatitis A Vaccine, Inactivated (VAQTA) 50/1.0 U/ml Injection, 1 dosage form administered as prophylaxis (lot number reported as Y017625, which has been verified as valid, expiration date reported and validated 11-JUL-2026) (Accidental overdose, Product administered to patient of inappropriate age). No symptoms had been reported in the patient. This is 1 of 2 reports from the same reporter.